Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Fluphenazine Decanoate

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Fluphenazine Decanoate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,282Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MSN Laboratories' Generic Fluphenazine Decanoate Receives Approval in the U.S.
    MSN Laboratories' Generic Fluphenazine Decanoate Receives Approval in the U.S.

    02 Nov 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215365

    FDA
    02 Nov 2023
    Share Share
    Fluphenazine decanoate injections – supply and reimbursement update
    Fluphenazine decanoate injections – supply and reimbursement update

    30 Oct 2020

    // ORG

    https://psnc.org.uk/our-news/discontinuation-notice-modecate-fluphenazine-decanoate/

    ORG
    30 Oct 2020
    Share Share
    Enforcement Report - Week of December 11, 2019
    Enforcement Report - Week of December 11, 2019

    11 Dec 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-11-2019-1576044384.pdf

    FDA
    11 Dec 2019
    Share Share
    Gattex (teduglutide), Amlodipine and Valsartan Tabs : Shire-NPS Pharm v. Par Pharma et al.
    Gattex (teduglutide), Amlodipine and Valsartan Tabs : Shire-NPS Pharm v. Par Pharma et al.

    30 Jul 2018

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/gattex-teduglutide-amlodipine-and-valsartan-tabs-shire-nps-pharm-v-par-pharma-et-al-1533038693.pdf

    PATENT LITIGATION
    30 Jul 2018
    Share Share
    Aurobindo Pharma’s Generic Fluphenazine Decanoate Receives Approval In US
    Aurobindo Pharma’s Generic Fluphenazine Decanoate Receives Approval In US

    20 Oct 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207739

    FDA
    20 Oct 2017
    Share Share
    Enforcement Report - Week of April 12, 2017
    Enforcement Report - Week of April 12, 2017

    12 Apr 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2017-1491972590.pdf

    FDA
    12 Apr 2017
    Share Share